Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated May 16, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2022. Go to the latest filing (Q3 2026)

24.6B USDQ1 2022
Total value of stock positions
24.6B USD
Positions
90
Share of the ten largest
40.2%

The ten largest positions Q1 2022

  1. T-Mobile US 7.0%▲ +2.1%
  2. Amazon 5.6%▲ +52.0%
  3. GE Aerospace 4.8%▼ −29.0%
  4. Microsoft 4.2%▲ +13.2%
  5. Brookfield Asset Mgmt Inc 3.7%▼ −7.4%
  6. Parker Hannifin 3.6%▲ +3.5%
  7. Fortive 3.0%▲ +41.8%
  8. Api Group Corp 2.9%▲ +0.4%
  9. Chubb Limited 2.8%▼ −13.3%
  10. Comcast 2.7%▼ −0.9%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q1 2022

Positions Q1 2022 per 13F filing, 31 of 31
Symbol Weight Shares Reported value Change Held since
TMUS T-Mobile US 7.0% 13,418,175 1.7B USD +2.1% increased Q1 2020 9 quarters
AMZN Amazon 5.6% 422,853 1.4B USD +52.0% increased Q2 2015 28 quarters
MSFT Microsoft 4.2% 3,319,116 1.0B USD +13.2% increased Q2 2016 24 quarters
PH Parker Hannifin 3.6% 3,165,334 898.2M USD +3.5% increased Q2 2020 8 quarters
FTV Fortive 3.0% 12,033,157 733.2M USD +41.8% increased Q3 2019 11 quarters
Api Group Corp 2.9% 33,463,200 703.7M USD +0.4% increased Q2 2020 8 quarters
WDAY Workday, Inc. 2.2% 2,253,470 539.6M USD +28.7% increased Q4 2021 2 quarters
AON Aon plc 2.1% 1,593,080 518.8M USD +5.5% increased Q4 2021 2 quarters
IFF International Flavors & Fragrances 2.0% 3,797,230 498.7M USD +643.1% increased Q4 2021 2 quarters
Hdfc Bank Ltd 1.8% 7,073,317 433.8M USD +45.8% increased Q3 2021 3 quarters
Royalty Pharma PLC 1.7% 10,764,472 419.4M USD +4.4% increased Q2 2020 8 quarters
Guardant Health Inc 1.6% 5,812,234 385.0M USD +14.5% increased Q3 2019 11 quarters
MRSH Marsh McLennan 1.6% 2,250,643 383.6M USD +78.4% increased Q4 2020 6 quarters
Match Group Inc New 1.2% 2,744,468 298.4M USD +44.5% increased Q4 2020 6 quarters
Biomarin Pharmaceutical Inc 1.2% 3,752,393 289.3M USD +30.7% increased Q4 2021 2 quarters
TMO Thermo Fisher Scientific 1.2% 484,696 286.3M USD +129.7% increased Q2 2020 8 quarters
NOW ServiceNow 1.0% 440,450 245.3M USD +96.4% increased Q4 2020 6 quarters
Catalent Inc 0.9% 1,893,644 210.0M USD +66.2% increased Q1 2018 17 quarters
Intellia Therapeutics Inc 0.7% 2,468,760 179.4M USD +56.3% increased Q2 2021 4 quarters
Global E Online Ltd 0.7% 5,128,448 173.2M USD +1.8% increased Q4 2021 2 quarters
BEKE KE Holdings 0.7% 13,440,125 166.3M USD +360.2% increased Q4 2021 2 quarters
LI Li Auto 0.6% 6,000,478 154.9M USD +33.8% increased Q4 2021 2 quarters
CRL Charles River Laboratories 0.6% 521,653 148.1M USD +33.7% increased Q1 2021 5 quarters
Acadia Healthcare Company In 0.6% 2,130,433 139.6M USD +1.9% increased Q4 2020 6 quarters
Zai Lab Ltd 0.6% 3,133,297 137.8M USD +3.8% increased Q1 2021 5 quarters
Karuna Therapeutics Inc 0.5% 974,345 123.5M USD +12.8% increased Q3 2020 7 quarters
Pvh Corporation 0.5% 1,542,375 118.2M USD +100.6% increased Q2 2020 8 quarters
Biohaven Pharmactl Hldg Co L 0.5% 966,139 114.6M USD +177.0% increased Q4 2021 2 quarters
Celldex Therapeutics Inc New 0.3% 1,846,647 62.9M USD +143.7% increased Q3 2021 3 quarters
Pharvaris N V 0.2% 2,480,319 46.4M USD +1.0% increased Q1 2021 5 quarters
Orion Acquisition Corp 0.2% 3,788,774 37.2M USD +3.3% increased Q1 2021 5 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 96.9M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 96.9M USD

Breakdown by sector

  • Industrials 14.9%
  • Financials 14.0%
  • Communication Services 11.1%
  • Health Care 7.8%
  • Technology 7.3%
  • Consumer Discretionary 6.8%
  • Materials 2.0%
  • Consumer Staples 0.4%
  • not in our coverage 35.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close